BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2347900)

  • 1. Expression of chromogranin-A messenger ribonucleic acid in parathyroid tissue from patients with primary hyperparathyroidism.
    Levine MA; Dempsey MA; Helman LJ; Ahn TG
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1668-73. PubMed ID: 2347900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-expression of parathyroid hormone and chromogranin A in secondary hyperparathyroidism: a functional marker for secretory activity of hyperplastic nodules.
    Tanaka R; Umemura S; Kakuta T; Fujisaki T; Sakai H; Saitoh A; Osamura RY
    Pathol Res Pract; 2003; 199(2):93-9. PubMed ID: 12747471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.
    Soliman E; Canaff L; Fox J; Hendy GN
    Endocrinology; 1997 Jun; 138(6):2596-600. PubMed ID: 9165053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone content distinguishes true normal parathyroids from parathyroids of patients with primary hyperparathyroidism.
    Weber CJ; Russell J; Chryssochoos JT; Hagler M; McGarity WC
    World J Surg; 1996 Oct; 20(8):1010-4; discussion 1014-5. PubMed ID: 8798358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreastatin, a chromogranin A-derived peptide, inhibits transcription of the parathyroid hormone and chromogranin A genes and decreases the stability of the respective messenger ribonucleic acids in parathyroid cells in culture.
    Zhang JX; Fasciotto BH; Darling DS; Cohn DV
    Endocrinology; 1994 Mar; 134(3):1310-6. PubMed ID: 8119171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships of parathyroid hormone, parathyroid secretory protein, parathyroid hormone messenger RNA, parathyroid secretory protein mRNA, and replication in human parathyroid adenoma and secondary hyperplasia tissues and cultures.
    Weber CJ; Russell J; Costanzo MK; Karp F; Benjamin M; Hardy MA; Feind CR
    Surgery; 1992 Dec; 112(6):1089-94; discussion 1094-5. PubMed ID: 1455310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromogranin A and B in parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study.
    Schmid KW; Hittmair A; Ladurner D; Sandbichler P; Gasser R; Tötsch M
    Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):295-9. PubMed ID: 2024450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of transcripts encoding a parathyroid hormone-related peptide in abnormal human parathyroid tissues.
    Ikeda K; Arnold A; Mangin M; Kinder B; Vydelingum NA; Brennan MF; Broadus AE
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1240-8. PubMed ID: 2573615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma chromogranin-A in primary hyperparathyroidism.
    Nanes MS; O'Connor DT; Marx SJ
    J Clin Endocrinol Metab; 1989 Nov; 69(5):950-5. PubMed ID: 2571619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
    Carling T; Rastad J; Szabó E; Westin G; Akerström G
    J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism.
    Farnebo F; Enberg U; Grimelius L; Bäckdahl M; Schalling M; Larsson C; Farnebo LO
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3481-6. PubMed ID: 9329389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of synthesis and secretion of chromogranin-A by calcium and 1,25-dihydroxycholecalciferol in cultured bovine parathyroid cells.
    Mouland AJ; Hendy GN
    Endocrinology; 1991 Jan; 128(1):441-9. PubMed ID: 1986936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone and calcium interact in the regulation of parathormone and chromogranin-A secretion and messenger ribonucleic acid levels in parathyroid cells.
    Zhang JX; Fasciotto BH; Cohn DV
    Endocrinology; 1993 Jul; 133(1):152-8. PubMed ID: 8319562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 production and secretion by human parathyroids.
    Safley SA; Villinger F; Jackson EH; Tucker-Burden C; Cohen C; Weber CJ
    Clin Exp Immunol; 2004 Apr; 136(1):145-56. PubMed ID: 15030526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenomedullin immunoreactivity tissue distribution in parathyroids of the patients with primary hyperparathyroidism.
    Letizia C; Ricci F; De Toma G; Cianci R; Alo P; Celi M; Panzironi G; Mingazzini PL; D'Erasmo E; Mazzuoli GF
    Horm Metab Res; 2004 Jul; 36(7):480-4. PubMed ID: 15305232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromogranin A and B messenger ribonucleic acids in pituitary and other normal and neoplastic human endocrine tissues.
    Lloyd RV; Iacangelo A; Eiden LE; Cano M; Jin L; Grimes M
    Lab Invest; 1989 Apr; 60(4):548-56. PubMed ID: 2709813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism.
    Cetani F; Picone A; Cerrai P; Vignali E; Borsari S; Pardi E; Viacava P; Naccarato AG; Miccoli P; Kifor O; Brown EM; Pinchera A; Marcocci C
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4789-94. PubMed ID: 11134144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine chromogranin A sequence and distribution of its messenger RNA in endocrine tissues.
    Iacangelo A; Affolter HU; Eiden LE; Herbert E; Grimes M
    Nature; 1986 Sep 4-10; 323(6083):82-6. PubMed ID: 3018587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma chromogranin A in pheochromocytoma, primary hyperparathyroidism and pituitary adenoma in comparison with catecholamine, parathyroid hormone and pituitary hormones.
    Kimura N; Miura W; Noshiro T; Mizunashi K; Hanew K; Shimizu K; Watanabe T; Shibukawa S; Sohn HE; Abe K; Miura Y; Nagura H
    Endocr J; 1997 Apr; 44(2):319-27. PubMed ID: 9228469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
    Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.